The trial is starting nowish: An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis.
They are conducting the study in the following US states:

United States, California
Collaborative Neuroscience Network, Inc.
Long Beach, California, United States, 90806
Contact: Anne Cabral, MS 562-304-1742 annecabral@cnstrial.com

University of California Davis Medical Center
Sacramento, California, United States, 95817
Contact: Janelle Butters 916-734-6276 janelle.butters@ucdmc.ucdavis.edu

United States, Colorado
IMMUNOe
Centennial, Colorado, United States, 80112
Contact: Ira Ling 303-224-4692 iling@immunoe.com

United States, Indiana
Indiana University
ndianapolis, Indiana, United States, 46202
Contact: Lee Hayward, BSN, RN, MSCN 317-278-7293 lhayward@iupui.edu

United States, Maryland
Parexel International
Baltimore, Maryland, United States, 22125
Contact: Pepi Pencheva, MD 410-350-7920 pepi.pencheva@parexel.com

United States, New York
University of Rochester Medical Center
Rochester, New York, United States, 14642
Contact: Eileen Scheid, RN, MSN 585-275-6673 eileen_scheid@urmc.rochester.edu

United States, Tennessee
New Orleans Center for Clinical Research (NOCCR)
Knoxville, Tennessee, United States, 37920
Contact: Debbie Demsey 865-305-9100 ddempsey@noccr.com

United States, Vermont
Fletcher Allen Health Care
Burlington, Vermont, United States, 05401
Contact: Patricia Krusinski, MSHS, CCRC 802-847-4256 patricia.krusinski@vtmednet.org

United States, Washington
Virginia Mason Medical Center (VMMC)
Seattle, Washington, United States, 98101
Contact: Leslie Stevens, CCRC 206-342-6929 Leslie.Stevens@vmmc.org

Multiple Sclerosis Center, Swedish Neuroscience Institute
Seattle, Washington,United States, 98122
Contact: Yuriko Courtney, CCRC 206-320-2200 Yuriko.Courtney@Swedish.org